1. Executive Summary
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Infusion Pumps Market
4. Market Overview
    4.1. Market Segmentation
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Infusion Pumps Market Analysis and Forecast, 2023-2031
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
    5.3. COVID-19 Pandemic Impact on Industry
6. Infusion Pumps Market Analysis and Forecast, by Product
    6.1. Introduction and Definitions
    6.2. Key Findings/Developments
    6.3. Market Value & Volume Forecast, by Product, 2023–2031
        6.3.1. Insulation Pumps
        6.3.2. PCA Pumps
        6.3.3. Enteral Pumps
        6.3.4. Others
    6.4. Market Attractiveness, by Product
7. Infusion Pumps Market Analysis and Forecast, by Application
    7.1. Introduction and Definitions
    7.2. Key Findings/Developments
    7.3. Market Value & Volume Forecast, by Application, 2023–2031
        7.3.1. Diabetes Management
        7.3.2. Pain Management
        7.3.3. Chemotherapy
        7.3.4. Others
    7.4. Market Attractiveness, by Application
8. Global Infusion Pumps Market Analysis and Forecast, by End-user
    8.1. Introduction and Definitions
    8.2. Key Findings/Developments
    8.3. Market Value & Volume Forecast, by End-user, 2023–2031
        8.3.1. Hospitals
        8.3.2. Ambulatory Care Settings
        8.3.3. Home Care Settings
        8.3.4. Others
    8.4. Market Attractiveness, by End-user
9. Global Infusion Pumps Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value & Volume Forecast, by Region, 2023–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness, by Region
10. North America Infusion Pumps Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value & Volume Forecast, by Product, 2023–2031
        10.2.1. Insulation Pumps
        10.2.2. PCA Pumps
        10.2.3. Enteral Pumps
        10.2.4. Others
    10.3. Market Attractiveness, by Product
    10.4. Market Value & Volume Forecast, by Application, 2023–2031
        10.4.1. Diabetes Management
        10.4.2. Pain Management
        10.4.3. Chemotherapy
        10.4.4. Others
    10.5. Market Attractiveness, by Application
    10.6. Market Value & Volume Forecast, by End-user, 2023–2031
        10.6.1. Hospitals
        10.6.2. Ambulatory Care Settings
        10.6.3. Home Care Settings
        10.6.4. Others
    10.7. Market Attractiveness, by End-user
    10.8. Market Value & Volume Forecast, by Country, 2023–2031
        10.8.1. U.S.
        10.8.2. Canada
    10.9. Market Attractiveness Analysis
        10.9.1. By Product
        10.9.2. By Application
        10.9.3. By End-user
        10.9.4. By Country
11. Europe Infusion Pumps Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value & Volume Forecast, by Product, 2023–2031
        11.2.1. Insulation Pumps
        11.2.2. PCA Pumps
        11.2.3. Enteral Pumps
        11.2.4. Others
    11.3. Market Attractiveness, by Product
    11.4. Market Value & Volume Forecast, by Application, 2023–2031
        11.4.1. Diabetes Management
        11.4.2. Pain Management
        11.4.3. Chemotherapy
        11.4.4. Others
    11.5. Market Attractiveness, by Application
    11.6. Market Value & Volume Forecast, by End-user, 2023–2031
        11.6.1. Hospitals
        11.6.2. Ambulatory Care Settings
        11.6.3. Home Care Settings
        11.6.4. Others
    11.7. Market Attractiveness, by End-user
    11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023–2031
        11.8.1. Germany
        11.8.2. U.K.
        11.8.3. France
        11.8.4. Italy
        11.8.5. Spain
        11.8.6. Rest of Europe
    11.9. Market Attractiveness Analysis
        11.9.1. By Product
        11.9.2. By Application
        11.9.3. By End-user
        11.9.4. By Country/Sub-region
12. Asia Pacific Infusion Pumps Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value & Volume Forecast, by Product, 2023–2031
        12.2.1. Insulation Pumps
        12.2.2. PCA Pumps
        12.2.3. Enteral Pumps
        12.2.4. Others
    12.3. Market Attractiveness, by Product
    12.4. Market Value & Volume Forecast, by Application, 2023–2031
        12.4.1. Diabetes Management
        12.4.2. Pain Management
        12.4.3. Chemotherapy
        12.4.4. Others
    12.5. Market Attractiveness, by Application
    12.6. Market Value & Volume Forecast, by End-user, 2023–2031
        12.6.1. Hospitals
        12.6.2. Ambulatory Care Settings
        12.6.3. Home Care Settings
        12.6.4. Others
    12.7. Market Attractiveness, by End-user
    12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023–2031
        12.8.1. China
        12.8.2. Japan
        12.8.3. India
        12.8.4. Australia & New Zealand
        12.8.5. Rest of Asia Pacific
    12.9. Market Attractiveness Analysis
        12.9.1. By Product
        12.9.2. By Application
        12.9.3. By End-user
        12.9.4. By Country/Sub-region
13. Latin America Infusion Pumps Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value & Volume Forecast, by Product, 2023–2031
        13.2.1. Insulation Pumps
        13.2.2. PCA Pumps
        13.2.3. Enteral Pumps
        13.2.4. Others
    13.3. Market Attractiveness, by Product
    13.4. Market Value & Volume Forecast, by Application, 2023–2031
        13.4.1. Diabetes Management
        13.4.2. Pain Management
        13.4.3. Chemotherapy
        13.4.4. Others
    13.5. Market Attractiveness, by Application
    13.6. Market Value & Volume Forecast, by End-user, 2023–2031
        13.6.1. Hospitals
        13.6.2. Ambulatory Care Settings
        13.6.3. Home Care Settings
        13.6.4. Others
    13.7. Market Attractiveness, by End-user
    13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023–2031
        13.8.1. Brazil
        13.8.2. Mexico
        13.8.3. Rest of Latin America
    13.9. Market Attractiveness Analysis
        13.9.1. By Product
        13.9.2. By Application
        13.9.3. By End-user
        13.9.4. By Country/Sub-region
14. Middle East & Africa Infusion Pumps Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value & Volume Forecast, by Product, 2023–2031
        14.2.1. Insulation Pumps
        14.2.2. PCA Pumps
        14.2.3. Enteral Pumps
        14.2.4. Others
    14.3. Market Attractiveness, by Product
    14.4. Market Value & Volume Forecast, by Application, 2023–2031
        14.4.1. Diabetes Management
        14.4.2. Pain Management
        14.4.3. Chemotherapy
        14.4.4. Others
    14.5. Market Attractiveness, by Application
    14.6. Market Value & Volume Forecast, by End-user, 2023–2031
        14.6.1. Hospitals
        14.6.2. Ambulatory Care Settings
        14.6.3. Home Care Settings
        14.6.4. Others
    14.7. Market Attractiveness, by End-user
    14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023–2031
        14.8.1. GCC Countries
        14.8.2. South Africa
        14.8.3. Rest of Middle East & Africa
    14.9. Market Attractiveness Analysis
        14.9.1. By Product
        14.9.2. By Application
        14.9.3. By End-user
        14.9.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
    15.2. Market Share Analysis, by Company (2022)
    15.3. Company Profiles
        15.3.1. ICU Medical Inc.
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Tandem Diabetes Care, Inc.
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Medtronic plc
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Terumo Corporation
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. F. Hoffmann-La Roche AG
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Baxter International
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. BD
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Fresenius Kabi AG
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. B. Braun SE
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. Insulet Corporation
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			